Screening Kinase Inhibitors with a Microarray-Based Fluorescent and Resonance Light Scattering Assay

被引:44
作者
Li, Tao [1 ,2 ]
Liu, Dianjun [1 ]
Wang, Zhenxin [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
关键词
PROTEIN; DESIGN; PHOSPHORYLATION; SPECIFICITY; POTENT; PROBES; TOOLS;
D O I
10.1021/ac902804h
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this technical note, a microarray-based spectroscopic assay with two readout principles, fluorescence and resonance light scattering (RLS), for screening kinase inhibitors has been reported. In this assay, the phosphorylation and inhibition events are marked by biotinylated antiphosphoserinen/antiphosphotyrosine antibodies, and gold nanoparticles are attached to the antibodies by standard avidin-biotin chemistry followed by silver deposition for HIS signal enhancement. The avidin conjugated fluorescein is used as a fluorescent probe. Assays for both serine kinase, the alpha-catalytic subunit of cyclic adenosine 5'-monophosphate (cAMP) dependent protein kinase (PKA), and tyrosine kinase, leukocyte-specific protein tyrosine kinase (LCK), have been developed. The utility of this assay to high-throughput screening was demonstrated with a commercial inhibitor library, a collection of 80 kinase inhibitors, and satisfactory results were obtained. In addition, quantitative determination of binding strength and the inhibiting type (type I) of these inhibitors are also demonstrated by the adenosine 5'-triphosphate (ATP) competing assays.
引用
收藏
页码:3067 / 3072
页数:6
相关论文
共 43 条
[1]   Detection of p56lck kinase activity using scintillation proximity assay in 384-well format and imaging proximity assay in 384-and 1536-well format [J].
Beveridge, M ;
Park, YW ;
Hermes, J ;
Marenghi, A ;
Brophy, G ;
Santos, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2000, 5 (04) :205-211
[2]   Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II [J].
Burchat, AF ;
Calderwood, DJ ;
Hirst, GC ;
Holman, NJ ;
Johnston, DN ;
Munschauer, R ;
Rafferty, P ;
Tometzki, GB .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) :2171-2174
[3]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[4]   PROTEIN-KINASE-C INHIBITORS INDUCE APOPTOSIS IN HUMAN-MALIGNANT GLIOMA CELL-LINES [J].
COULDWELL, WT ;
HINTON, DR ;
HE, SK ;
CHEN, TC ;
SEBAT, I ;
WEISS, MH ;
LAW, RE .
FEBS LETTERS, 1994, 345 (01) :43-46
[5]   Protein and peptide arrays: Recent trends and new directions [J].
Cretich, M ;
Damin, F ;
Pirri, G ;
Chiari, M .
BIOMOLECULAR ENGINEERING, 2006, 23 (2-3) :77-88
[6]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[7]   An array of options: proteomics gets parallel [J].
Dove, A .
NATURE METHODS, 2005, 2 (09) :709-+
[8]  
Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17
[9]   CONTROLLED NUCLEATION FOR REGULATION OF PARTICLE-SIZE IN MONODISPERSE GOLD SUSPENSIONS [J].
FRENS, G .
NATURE-PHYSICAL SCIENCE, 1973, 241 (105) :20-22
[10]   Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease [J].
Georganopoulou, DG ;
Chang, L ;
Nam, JM ;
Thaxton, CS ;
Mufson, EJ ;
Klein, WL ;
Mirkin, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2273-2276